Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Lyumjev vs Humalog in T1DM
NCT03166124Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2017
- Primary completion
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin lispro in type 1 diabetes mellitus (T1D) (4 arms), sponsored by Eli Lilly and Company. Primary endpoint: Insulin Lispro Area Under the Concentration Versus Time Curve. Started May 2017; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03166124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03166124.